Skip to main content
. 2017 Jul 27;7:6703. doi: 10.1038/s41598-017-06949-8

Figure 5.

Figure 5

Antibody recovery by the microfluidic cell retention device. (a) Antibody concentrations from the bioreactor and outer outlet (the permeate stream) of the device were compared daily. Error bars, data range (n = 3, technical replicates). (b) The recovery efficiency close to 100% demonstrates that the microfluidic cell retention device does not suffer from the low product recovery, compared with the membrane-based filtration technologies.